CPHI Milan 2
CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
Freeze-drying with Collapse is not Necessarily Bad for Stability and can Reduce Cost – Sophie Declomesnil, LYOFAL – Groupe SYNERLAB
Editorial Archive

Freeze-drying with Collapse is not Necessarily Bad for Stability and can Reduce Cost – Sophie Declomesnil, LYOFAL – Groupe SYNERLAB

Lyophilisation is often used to increase the stability and shelf-life proteins which are physically and/or chemically unstable in aqueous solution. Freeze-drying rem...
Continue Reading →
Syringe Siliconisation Trends, Methods, Analysis Procedures -Claudia Petersen and Bernd Zeiss, Gerresheimer
Editorial Archive

Syringe Siliconisation Trends, Methods, Analysis Procedures -Claudia Petersen and Bernd Zeiss, Gerresheimer

Ready-to-fill, i.e. sterile, prefillable glass syringes, are washed, siliconised, sterilised and packaged by the primary packaging manufacturer. They can then be fil...
Continue Reading →
LIMS as an Enabling Technology for the Pharmaceutical Industry -John Boother,  Autoscribe Ltd
Editorial Archive

LIMS as an Enabling Technology for the Pharmaceutical Industry -John Boother, Autoscribe Ltd

In the pharmaceutical industry, just as in many other industries, the purchase of a laboratory information management system (LIMS) is not a trivial exercise and req...
Continue Reading →
Obtaining European Regulator y Approval – Graham Donaldson, TRAC Services
Editorial Archive

Obtaining European Regulator y Approval – Graham Donaldson, TRAC Services

The aim of this article is to provide an overview of the European regulatory environment and to outline some of the main pharmaceutical regulations and requirements ...
Continue Reading →
Track-and-Trace – A Challenge for IT – Barbara Schleper – Awikom
Editorial Archive

Track-and-Trace – A Challenge for IT – Barbara Schleper – Awikom

Although a few years ago the number of impressive reference projects and the price of a track-and-trace solution were the deciding factors when selecting a provider,...
Continue Reading →
The Present and Future of Non-Vascular Stents – Debarati Sengupta and Bhargav Rajan, Frost & Sullivan,
Clinical Research V7 I2

The Present and Future of Non-Vascular Stents – Debarati Sengupta and Bhargav Rajan, Frost & Sullivan,

In our fascination for new-age medical devices such as smart pills and wearable health devices, we do not often pause to think about some of the less-fancy, but equa...
Continue Reading →
Allergy Therapies: Increasing the Probability of Clinical Development Success -Dr Juan Gispert, Quintiles
Clinical Research V7 I2

Allergy Therapies: Increasing the Probability of Clinical Development Success -Dr Juan Gispert, Quintiles

The prevalence of allergic diseases is increasing sharply in both developed and developing countries. These diseases include: asthma; rhinitis; anaphylaxis; drug, fo...
Continue Reading →
ISO IDMP Short Timelines and Limited Information: How Do You Solve the Challenges and Prioritise your Efforts? – Rune Berggendorf, NNIT
Drug Discovery, Development and Delivery

ISO IDMP Short Timelines and Limited Information: How Do You Solve the Challenges and Prioritise your Efforts? – Rune Berggendorf, NNIT

ISO IDMP has been around since 2012, when the standards were initially published, and since November 2012 the implementing regulation 520/2012 has been in place. Now...
Continue Reading →
The Virtual Elaboration of Fragment Ideas – Dr Martin Slater, Cresset
Drug Discovery, Development and Delivery V7 I2

The Virtual Elaboration of Fragment Ideas – Dr Martin Slater, Cresset

Growing, Merging and Linking Fragments with Realistic Chemistry Dr Robert Scoffin and Dr Martin Slater from Cresset serve readers with a fragment-based drug discover...
Continue Reading →
The Cambridge/London Corridor: Its Strength and Impact on the UK – Harriet Fear, One Nucleus
Editorial Archive

The Cambridge/London Corridor: Its Strength and Impact on the UK – Harriet Fear, One Nucleus

The UK has one of the strongest and most productive life sciences sectors in the world, generating turnover of over £50 billion. There are nearly 5000 companies in t...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026